Answers are grounded in this paper and cite their sources.
Interferon has limited in vivo antitumor activity when host tumor load is great. When systemic leukemia is arrested by drug therapy which leads to a reduction of tumor cells, subsequent treatment with interferon leads to a significant number of cures. The combined drug and interferon treatment exerts a synergistic antitumor effect.
No takes yet. Share an insight, caveat, or question.
Chirigos et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: